Your browser doesn't support javascript.
loading
FAS2FURIOUS: Moderate-Throughput Secreted Expression of Difficult Recombinant Proteins in Drosophila S2 Cells.
Coker, Jesse A; Katis, Vittorio L; Fairhead, Michael; Schwenzer, Anja; Clemmensen, Stine B; Frandsen, Bent U; de Jongh, Willem A; Gileadi, Opher; Burgess-Brown, Nicola A; Marsden, Brian D; Midwood, Kim S; Yue, Wyatt W.
Afiliación
  • Coker JA; Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Katis VL; Kennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom.
  • Fairhead M; Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Schwenzer A; Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Clemmensen SB; Kennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom.
  • Frandsen BU; ExpreS2ion Biotechnologies, SCION-DTU Science Park, Hørsholm, Denmark.
  • de Jongh WA; ExpreS2ion Biotechnologies, SCION-DTU Science Park, Hørsholm, Denmark.
  • Gileadi O; ExpreS2ion Biotechnologies, SCION-DTU Science Park, Hørsholm, Denmark.
  • Burgess-Brown NA; Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Marsden BD; Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Midwood KS; Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Yue WW; Kennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom.
Front Bioeng Biotechnol ; 10: 871933, 2022.
Article en En | MEDLINE | ID: mdl-35600892
Recombinant protein expression in eukaryotic insect cells is a powerful approach for producing challenging targets. However, due to incompatibility with standard baculoviral platforms and existing low-throughput methodology, the use of the Drosophila melanogaster "S2" cell line lags behind more common insect cell lines such as Sf9 or High-Five™. Due to the advantages of S2 cells, particularly for secreted and secretable proteins, the lack of a simple and parallelizable S2-based platform represents a bottleneck, particularly for biochemical and biophysical laboratories. Therefore, we developed FAS2FURIOUS, a simple and rapid S2 expression pipeline built upon an existing low-throughput commercial platform. FAS2FURIOUS is comparable in effort to simple E. coli systems and allows users to clone and test up to 46 constructs in just 2 weeks. Given the ability of S2 cells to express challenging targets, including receptor ectodomains, secreted glycoproteins, and viral antigens, FAS2FURIOUS represents an attractive orthogonal approach for protein expression in eukaryotic cells.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Front Bioeng Biotechnol Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Front Bioeng Biotechnol Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido